3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
70
Rectal Neoplasms
29
Colonic Neoplasms
28
Carcinoma, Hepatocellular
26
Neoplasm Metastasis
15
Stomach Neoplasms
12
Pancreatic Neoplasms
7
Cholangiocarcinoma
6
Adenocarcinoma Of Esophagus
6
Esophageal Neoplasms
5
Recurrence
4
Liver Neoplasms
4
Biliary Tract Neoplasms
4
Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Gastrointestinal Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Adenocarcinoma
2
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Pancreatic Adenocarcinoma
1
Operable T2-3N+M0 Rectal Cancer (Stage III)
1
Oligometastatic Gastric Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neuropathy, Painful
1
Neuralgia
1
Interventions
Diathermy
20
Radiotherapy
11
Fluorouracil
4
Drug Therapy
4
Cisplatin
4
Radiation
3
Immune Checkpoint Inhibitors
3
Brachytherapy
3
tislelizumab
2
Surgical Procedures, Operative
2
Solutions
2
Immunotherapy
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Conization
2
Capecitabine
2
spartalizumab
1
anlotinib
1
Temozolomide
1
Saline Solution
1
Radiation Dose Hypofractionation
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Ifosfamide
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gemcitabine
1
Folfox protocol
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hyperthermia
×
Folfox protocol
×
Clear all
NCT06831981
2025-02-18
ARO 2024-13
University Hospital Tuebingen
Phase NA
Recruiting
264 enrolled